hydroxyurea has been researched along with Atrioventricular Nodal Re-Entrant Tachycardia in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cardiovascular side effects such as ventricular tachycardia and cardiomyopathy are rare but potentially fatal and should be made known to patients before starting the medication." | 1.48 | Ventricular tachyarrhythmia in a 78-year-old woman with essential thrombocythaemia. ( Greenspan, A; Lu, M; Rodriguez-Ziccardi, M; Rubio, M, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rodriguez-Ziccardi, M | 1 |
| Rubio, M | 1 |
| Lu, M | 1 |
| Greenspan, A | 1 |
1 other study available for hydroxyurea and Atrioventricular Nodal Re-Entrant Tachycardia
| Article | Year |
|---|---|
Ventricular tachyarrhythmia in a 78-year-old woman with essential thrombocythaemia.
Topics: Age Factors; Aged; Electrocardiography; Female; Humans; Hydroxyurea; Platelet Aggregation Inhibitors | 2018 |